Welcome at Drug Research Centre (DRC) for Bioequivalence and Biowaiver Studies, and other Advanced Pharmaceutical Research. Drug Research Centre is a full function CRO with a prime objective of supplying our customers and health authorities the highest standard of drug evaluation in bioequivalence and Biowaiver studies. Our centre operates state-of-the-art facilities specializing in method development and validation, and analysis of drugs and metabolites in plasma, blood and urine. Our centre has a proven record for flexible service and accurate results. We are serious about our research and studies, most caring and devoted to the benefit of patient.
"Always remember that the Target and Main Objective of Drug Research Centre is achieving the peak of Patient Benefit and Patient Care all over the world".
- Drug Research Centre (DRC) perform Bioequivalence studies & Biowaiver studies based on CAPA guidelines & international regulations on Good Clinical Practice provided by benchmark regulatory bodies like World Health organization (WHO), U.S Food & Drug Administration (FDA), EMEA (European Agency For The Evaluation of Medicinal Products) and ICH (International Conference of Technical Requirements for the Registration of Pharmaceuticals for Human Use).
- Drug Research Centre (DRC) possesses sufficient facilities, equipment and a well-established organization so that clinical observations, evaluation, and necessary procedures for preforming all needed Bioequivalence studies
- In Drug Research Centre (DRC) Investigators maintain the integrity of the clinical trial to ensure accuracy and precision of the results.